Highlights

  • Monvia (ASX:MNV) reported FY26 adjusted Revenue of A$27.7 million, adjusted EBITDA of A$6.9 million and adjusted NPAT of A$6.5 million.
  • Annual Recurring Revenue stood at A$14 million as at 1 July 2026, representing about half of adjusted revenue.
  • The renewal of its largest client, MetLife, on a five-year contract provides revenue visibility while the company pursues new clients across the region.

Monvia (ASX:MNV) has entered the ASX with an existing Earnings base rather than a pre-revenue software proposition. Its first FY26 result as a listed company showed A$27.7 million of adjusted revenue and A$6.9 million of adjusted EBITDA, while annual recurring revenue stood at A$14 million at the start of July 2026. The five-year renewal of its largest client, MetLife, adds visibility, but it also highlights customer concentration as an important issue for a relatively small enterprise-software provider.

Company Overview

Monvia supplies cloud-native software to the Life insurance industry. Its platform covers policy administration, new business, claims management and digital integration, replacing or augmenting legacy systems used by insurers. Revenue includes recurring licence and subscription income as well as implementation and service work. The company is focused on Australia and New Zealand while pursuing opportunities in Asia. Monvia began trading on the ASX on 24 July 2026, giving investors only a short listed track record to assess so far.

Financial and Operational Position

For FY26, Monvia reported adjusted revenue of A$27.7 million, adjusted EBITDA of A$6.9 million and adjusted net profit after tax of A$6.5 million. Annual recurring revenue was A$14 million as at 1 July 2026, equivalent to about half of adjusted revenue and providing a measure of the contracted or repeating portion of the business. The company reported pro forma cash of A$11.1 million and pro forma Debt of A$6.0 million. Operationally, the most notable disclosure was the renewal of MetLife, Monvia's largest customer, on a five-year contract with improved commercial terms. Management has also pointed to a pipeline across Australia, New Zealand and Asia as it seeks to broaden the customer base.

What Investors May Watch Next

The main growth test is whether Monvia can add new enterprise customers while maintaining retention and pricing across its existing base. Annual recurring revenue is likely to be a useful measure because it reduces the noise created by implementation work and project timing. Investors may also watch the balance between product Investment and cash generation, as well as expansion into Asia where sales cycles can be lengthy. The next half-year result should provide the first post-listing indication of whether the current pipeline is converting into additional recurring revenue.

Risks

Customer concentration remains the clearest exposure because a large client can materially affect revenue and earnings if a relationship changes. The five-year MetLife renewal reduces near-term renewal uncertainty but does not eliminate concentration risk. Enterprise insurance software has long procurement and implementation cycles, which can make new-business revenue uneven. Adjusted earnings measures may differ from statutory outcomes, and the company has only a limited public reporting history. Competition also includes much larger global core-insurance software vendors with greater sales and development resources.

Key Takeaways

Monvia's first ASX reporting period gives investors three practical measures: A$14 million of recurring revenue, profitable adjusted earnings and a five-year renewal with its largest customer. The next phase is about diversification. New client wins and further recurring-revenue growth would reduce dependence on the existing base and provide a clearer test of how scalable the platform can become across the region. Until that happens, customer concentration remains as important as the headline profitability.